CloudMD Announces Late Filing of Annual Financial Statements
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company”...
Healthcare
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
Libervant is the first and only FDA approved orally administered rescue product for the treatment of seizure clusters in patients...
BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading...
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities.The converted common stock is...
Capsa’s New NexPak Addresses Medication Administration Efficiencies In Correctional Care
COLUMBUS, Ohio, April 26, 2024 (GLOBE NEWSWIRE) -- Addressing the medication requirements of incarcerated individuals in U.S. correctional facilities has...
LevelJump Announces Acquisition of Pre-1954 Pharmacy Charter
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or...
LevelJump Announces MCTO Application Denied
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or the "Company")...
PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency
LARGO, FL / ACCESSWIRE / April 26, 2024 / PharmaLink Inc., a national leader in pharmaceutical reverse distribution, and Recall...
HCA Healthcare Reports First Quarter 2024 Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31,...
CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide
NASHVILLE, TN / ACCESSWIRE / April 26, 2024 / The latest data from the US Census Bureau reflects alarming statistics...
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding...
Curiteva Announces David Schmidt as Chief Commercial Officer
HUNTSVILLE, AL / ACCESSWIRE / April 26, 2024 / Curiteva, a privately held manufacturing and technology company, announces the appointment...
Biotricity’s Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2024 / Biotricity Inc. (NASDAQ:BTCY), a pioneering Technology-as-a-Service (TaaS) company dedicated to...
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital...
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 26, 2024...
Smart for Life Announces Availability of a White Paper on the Nutraceuticals Industry
White Paper Details Recent Trends and Provides Current Industry Data and Analysis on the Growing Nutraceutical IndustryMIAMI, April 26, 2024...
Johnson & Johnson receives positive CHMP opinion for RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S...
The Ensign Group Schedules First Quarter Earnings Call for Thursday, May 2, 2024
SAN JUAN CAPISTRANO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group...
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company...